Search research articles
Contact Us
Filters
Showing results (181-190 of 385) with videos related to
Page
of 39
Sort By:
Genome Medicine
|
April 18, 2014
Transcriptional dissection of pancreatic tumors engrafted in mice
Raquel Martinez-Garcia, David Juan, Antonio Rausell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity
Linda A deGraffenried, William E Friedrichs, Douglas H Russell, et al.
Cirugia Espanola
|
August 22, 2015
Acute mesenteric ischemia: Utility of endovascular techniques
Anna Serracant Barrera, Alexis Luna Aufroy, José Manuel Hidalgo Rosas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogue
Carlton K K Lee, Eric K Rowinsky, Jing Li, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Benzoylphenylurea sulfur analogues with potent antitumor activity
Gurulingappa Hallur, Antonio Jimeno, Susan Dalrymple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer
Manuel Hidalgo, Jan C Buckner, Charles Erlichman, et al.
Marine Environmental Research
|
January 5, 2023
The trade-off between condition and growth shapes juveniles' survival of harvested demersal fish of the Mediterranean sea
Georgios Karametsidis, Lucía Rueda, José M Bellido, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2008
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
Wells A Messersmith, Antonio Jimeno, David Ettinger, et al.
BMC Cancer
|
April 23, 2008
Methylation alterations are not a major cause of PTTG1 misregulation
Manuel Hidalgo, Jose Jorge Galan, Carmen Sáez, et al.
Journal of the National Cancer Institute
|
December 7, 2006
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis, Vanesa Gregorc, Jing Li, et al.
Page
of 39
Search research articles
Search
Showing results (181-190 of 385) with videos related to
Sort By:
Page
of 39
Genome Medicine
|
April 18, 2014
Transcriptional dissection of pancreatic tumors engrafted in mice
Raquel Martinez-Garcia, David Juan, Antonio Rausell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity
Linda A deGraffenried, William E Friedrichs, Douglas H Russell, et al.
Cirugia Espanola
|
August 22, 2015
Acute mesenteric ischemia: Utility of endovascular techniques
Anna Serracant Barrera, Alexis Luna Aufroy, José Manuel Hidalgo Rosas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogue
Carlton K K Lee, Eric K Rowinsky, Jing Li, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Benzoylphenylurea sulfur analogues with potent antitumor activity
Gurulingappa Hallur, Antonio Jimeno, Susan Dalrymple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer
Manuel Hidalgo, Jan C Buckner, Charles Erlichman, et al.
Marine Environmental Research
|
January 5, 2023
The trade-off between condition and growth shapes juveniles' survival of harvested demersal fish of the Mediterranean sea
Georgios Karametsidis, Lucía Rueda, José M Bellido, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2008
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
Wells A Messersmith, Antonio Jimeno, David Ettinger, et al.
BMC Cancer
|
April 23, 2008
Methylation alterations are not a major cause of PTTG1 misregulation
Manuel Hidalgo, Jose Jorge Galan, Carmen Sáez, et al.
Journal of the National Cancer Institute
|
December 7, 2006
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis, Vanesa Gregorc, Jing Li, et al.
Page
of 39